Rapamycin extends life span of Rb1+/- mice by inhibiting neuroendocrine tumors

Aging

Volumn 5, Issue 2, 2013, Pages 100-110

  Livi, Carolina B ^a,b,c   Hardman, Rulon L ^b   Christy, Barbara A ^a,b,c   Dodds, Sherry G ^a,b   Jones, Diane ^a,b   Williams, Charnae ^a,b   Strong, Randy ^a,b,c,d   Bokov, Alex ^a,b   Javors, Martin A ^a,b   Ikeno, Yuji ^a,b,d   Hubbard, Gene ^a,b   Hasty, Paul ^a,b,c   Sharp, Zelton Dave ^a,b,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c University of Texas Health Science Center at San Antonio   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

MTOR; Neuroendocrine tumors; Rapamycin; Rb1

Indexed keywords

EID: 84874987821     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100533     Document Type: Article

References (43)

1. Kirkwood TB. Gerontology: Healthy old age. Nature. 2008; 455:739-740.
2. Blagosklonny MV, Campisi J. Cancer and aging: more puzzles, more promises? Cell Cycle. 2008; 7:2615-2618.
3. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review 1975-2007 Bethesday, MD: National Cance Institute; 2010. Available from: http://seer.cancer.gov/csr/1975 2007//, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
4. Sharp Z, Richardson A. Aging and cancer: can mTOR inhibitors kill two birds with one drug? Targeted Oncology. 2011; 6:41-51.
5. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010; 31:83-89.
6. Fontana L, Partridge L, Longo VD. Extending Healthy Life Span- -From Yeast to Humans. Science. 2010; 328:321-326.
7. Weindruch R, Colman RJ, Pérez V, Richardson AG. How Does Calorie Restriction Increase the Longevity of Mammals? In: Guarente LP, Partridge L, Wallace DC, editors. Molecular Biology of Aging. Cold Spring Harbor, NY 11724: Cold Spring Harbor Laboratory Press; 2008; 409-426.
8. Bartke A. Growth hormone, insulin and aging: The benefits of endocrine defects. Exp Gerontol. 2011; 46:108-111.
9. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed Occurrence of Fatal Neoplastic Diseases in Ames Dwarf Mice: Correlation to Extended Longevity. J Gerontol A Biol Sci Med Sci. 2003; 58:B291-B296.
10. Ikeno Y, Hubbard GB, Lee S, Cortez LA, Lew CM, Webb CR, et al. Reduced Incidence and Delayed Occurrence of Fatal Neoplastic Diseases in Growth Hormone Receptor/Binding Protein Knockout Mice. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2009; 64A:522-529.
11. Powers RW, 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006; 20:174-184.
12. Robida-Stubbs S, Glover-Cutter K, Lamming DW, Mizunuma M, Narasimhan SD, Neumann-Haefelin E, et al. TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metabolism. 2012;15:713-724.
13. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster. Cell Metabolism. 2010; 11:35-46.
14. Nadon NL, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, et al. Design of aging intervention studies: the NIA interventions testing program. AGE. 2008; 30:187-199.
15. Nadon NL, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, et al. Design of aging intervention studies: the NIA interventions testing program. Age (Dordr). 2008; 30:187-199.
16. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460:392-395.
17. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice. J Gerontol A Biol Sci Med Sci. 2011; 66:191-201.
18. Zheng L, Lee WH. The retinoblastoma gene: a prototypic and multifunctional tumor suppressor. Exp Cell Res. 2001; 264:2-18.
19. Nikitin AY, Juarez-Perez MI, Li S, Huang L, Lee WH. RBmediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. Proc Natl Acad Sci U S A. 1999 Mar 30; 96:3916-3921.
20. Sharp ZD, Lee WH, Nikitin AY, Flesken-Nikitin A, Ikeno Y, Reddick R, et al. Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice. Carcinogenesis. 2003; 24:179-183.
21. Nikitin A, Lee WH. Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice. Genes Dev. 1996; 10:1870-1879.
22. Laplante M, Sabatini DM. mTOR Signaling in Growth Control and Disease. Cell. 2012; 149:274-293.
23. Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005;126:913-922.
24. Dhahbi JM, Kim HJ, Mote PL, Beaver RJ, Spindler SR. Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci U S A. 2004; 101:5524-5529.
25. Pool SE, Bison S, Koelewijn SJ, van der Graaf LM, Melis M, Krenning EP, et al. mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreaticneuroendocrine cancer. Cancer Res. 2013; 73:12-18.
26. Li B, Gordon GM, Du CH, Xu J, Du W. Specific killing of Rb mutant cancer cells by inactivating TSC2. Cancer Cell. 2010; 17:469-480.
27. El-Naggar S, Liu Y, Dean DC. Mutation of the Rb1 Pathway Leads to Overexpression of mTor, Constitutive Phosphorylation of Akt on Serine 473, Resistance to Anoikis and a Block in c-Raf Activation. Mol Cell Biol. 2009; 29:5710-5717.
28. Costa C, Santos M, Segrelles C, Duenas M, Lara MF, Agirre X, et al. A Novel Tumor suppressor network in squamous malignancies. Sci Rep. 2012; 2:828.
29. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice. Am J Pathol. 2010; 176:2092-2097.
30. Comas M, Toshkov I, Kuropatwinski KK, Chernova OB, Polinsky A, Blagosklonny MV, et al. New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis. Aging (Albany NY). 2012; 4: 715-722.
31. Komarova EA, Antoch MP, Novototskaya LR, Chernova OB, Paszkiewicz G, Leontieva OV, et al. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice. Aging (Albany NY). 2012; 4:709-714.
32. Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol. 2012; 181:278-293.
33. Blagosklonny MV. Prevention of cancer by inhibiting aging. Cancer Biol Ther. 2008; 7:1520-1524.
34. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012; 485:55-61
35. Dogliotti L, Tampellini M, Stivanello M, Gorzegno G, Fabiani L. The clinical management of neuroendocrine tumors with longacting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy. Ann Oncol. 2001; 12:Suppl 2:S105-109.
36. Pavel ME, Hainsworth JD, Baudin E, Peeters M, Horsch D, Winkler RE, et al. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study. Lancet. 2011; 378:2005-2012.
37. Nikitin A, Shan B, Flesken-Nikitin A, Chang KH, Lee WH. The retinoblastoma gene regulates somatic growth during mouse development. Cancer Res. 2001; 61:3110-3118.
38. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992; 359:288-294.
39. Therneau TM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
40. Therneau TM. A package for Survival in S. Rochester, MN: Mayo Foundation; 2012.
41. Team RDC. R: A Language and Environment for Statistical Computing 2012. Available from: http://www.R-project.org.
42. Bronson RT, Lipman RD. Reduction in rate of occurrence of age related lesions in dietary restricted laboratory mice. Growth Dev Aging. 1991; 55:169-184.
43. Ikeno Y, Hubbard GB, Lee S, Richardson A, Strong R, Diaz V, et al. Housing Density Does Not Influence the Longevity Effect of Calorie Restriction. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2005; 60:1510-1517.